Evidence map›Paper›PMID 37248412›Full record

ArticleNature chemical biology2023

Nucleophilic covalent ligand discovery for the cysteine redoxome.

Ling Fu, Youngeun Jung, Caiping Tian, Renan B Ferreira, Ruifeng Cheng, Fuchu He, Jing Yang, Kate S Carroll

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Friends, foes and signals.Nature chemical biology · 2026
    Article
  7. Review
  8. A druggable redox switch on SHP1 controls macrophage inflammation.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Profiling the landscape of cysteine posttranslational modifications in brain aging and neurodegeneration.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Ling Fu *State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing, Beijing Institute of Lifeomics, Beijing, China.
Youngeun Jung *Department of Chemistry, UF Scripps Biomedical Research, Jupiter, FL, USA.
Caiping TianState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing, Beijing Institute of Lifeomics, Beijing, China.
Renan B FerreiraDepartment of Chemistry, UF Scripps Biomedical Research, Jupiter, FL, USA.
Ruifeng ChengState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing, Beijing Institute of Lifeomics, Beijing, China.
Fuchu HeState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing, Beijing Institute of Lifeomics, Beijing, China.
Jing YangState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing, Beijing Institute of Lifeomics, Beijing, China. yangjing@ncpsb.org.cn.ORCID 0000-0001-8486-273X
Kate S CarrollDepartment of Chemistry, UF Scripps Biomedical Research, Jupiter, FL, USA. kate.carroll@ufl.edu.ORCID 0000-0002-7624-9617
Beijing Proteome Research Center · CNScripps (United States) · USAnhui Medical University · CNScripps Research Institute · US

Funding

Sulfur Metabolism in Human PathogensR01GM087638 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARROLL, KATE SUZANNE · 2009 to 2025
$5.0M
Probing the role of cysteine sulfenylation in cell signalingR01GM102187 · NIGMS · UNIVERSITY OF FLORIDA · PI Kate Suzanne Carroll · 2012 to 2026
$4.6M
Nucleophilic Inhibitors for Targeting Redox-Sensitive KinasesR01CA174864 · NCI · SCRIPPS FLORIDA · PI CARROLL, KATE SUZANNE · 2014 to 2017
$1.6M
Nucleophile-Fragment Screening for Site-Specific Covalent Ligand Discovery in Opioid Receptor SignalingR21DA059363 · NIDA · UNIVERSITY OF FLORIDA · PI CARROLL, KATE SUZANNE · 2024 to 2025
$425k
Targeting Oxidized PTP1B for Anticancer Drug DiscoveryR03CA289646 · NCI · UNIVERSITY OF FLORIDA · PI CARROLL, KATE SUZANNE · 2024 to 2025
$173k
National Natural Science Foundation of China (National Science Foundation of China) 21922702NCI NIH HHS R01 CA174864NCI NIH HHS R03 CA289646NIDA NIH HHS R21 DA059363NIGMS NIH HHS R01 GM087638NIGMS NIH HHS R01 GM102187U.S. Department of Health & Human Services | National Institutes of Health (NIH) GM087638U.S. Department of Health & Human Services | National Institutes of Health (NIH) GM102187
6 · The paper itself

Abstract

With an eye toward expanding chemistries used for covalent ligand discovery, we elaborated an umpolung strategy that exploits the 'polarity reversal' of sulfur when cysteine is oxidized to sulfenic acid, a widespread post-translational modification, for selective bioconjugation with C-nucleophiles. Here we present a global map of a human sulfenome that is susceptible to covalent modification by members of a nucleophilic fragment library. More than 500 liganded sulfenic acids were identified on proteins across diverse functional classes, and, of these, more than 80% were not targeted by electrophilic fragment analogs. We further show that members of our nucleophilic fragment library can impair functional protein-protein interactions involved in nuclear oncoprotein transport and DNA damage repair. Our findings reveal a vast expanse of ligandable sulfenic acids in the human proteome and highlight the utility of nucleophilic small molecules in the fragment-based covalent ligand discovery pipeline, presaging further opportunities using non-traditional chemistries for targeting proteins.

Indexed as

CysteineSulfenic AcidsHumansLigandsProtein Processing, Post-TranslationalProteomeCysteineLigandsProteomeSulfenic Acids

Identifiers

PMID37248412
PMCPMC12262106
OpenAlexW4378672626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.